The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy
- 4 March 2017
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 163 (2) , 273-279
Abstract
As mastectomy rates increase and overall survival for early breast cancer improves, a better understanding of the long-term consequences of mastectomy is needed. We sought to explore the correlation of specific mastectomy type with the Female Sexual Function Index (FSFI), body image satisfaction, and the reconstructed breast’s role in intimacy.Keywords
This publication has 29 references indexed in Scilit:
- Psychometric validation of the female sexual function index (FSFI) in cancer survivorsCancer, 2012
- Contralateral Prophylactic Mastectomy: Long-Term Consistency of Satisfaction and Adverse Effects and the Significance of Informed Decision-Making, Quality of Life, and Personality TraitsAnnals of Surgical Oncology, 2011
- Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality?Breast Cancer Research and Treatment, 2008
- Premature Ovarian Failure and Its Consequences: Vasomotor Symptoms, Sexuality, and FertilityJournal of Clinical Oncology, 2008
- Sexual Quality of Life in Women with Newly Diagnosed Breast CancerJournal of Psychosocial Oncology, 2007
- Breast Cancer Diagnosis and Its Treatment Affecting the SelfCancer Nursing, 2007
- Sexual Problems in Younger Women After Breast Cancer SurgeryJournal of Clinical Oncology, 2006
- Psychological impact and cosmetic outcome of surgical breast cancer strategiesAnz Journal of Surgery, 2005
- Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast CancerNew England Journal of Medicine, 2002
- Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast CancerNew England Journal of Medicine, 2002